Markets:

Overview

News

Currencies

International

Treasuries

MeiraGTx Holdings plc - Ordinary Shares (NQ:MGTX)

7.240 -0.170 (-2.29%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MeiraGTx Holdings plc - Ordinary Shares

< Previous 1 2 3 4 Next >

The Biotech Tug-of-War: Is Kiora Pharmaceuticals Positioned to Ride the 2025 Commodity Wave?

December 18, 2025

As of December 18, 2025, the financial landscape is defined by a stark divergence in the commodities market, creating a complex environment for clinical-stage biotechnology firms. While gold prices...

Via MarketMinute

MeiraGTx Reports Third Quarter 2025 Financial and Operational Results

November 13, 2025

From MeiraGTx

Via GlobeNewswire

MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗

November 10, 2025

Via Stocktwits

Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration ↗

November 10, 2025

MeiraGTx shares rise after signing a $475 million deal with Eli Lilly for a gene therapy program restoring vision in children with LCA4.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology

November 10, 2025

From MeiraGTx

Via GlobeNewswire

MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

October 07, 2025

Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms

From MeiraGTx

Via GlobeNewswire

MeiraGTx Sales Jump 1,133 Percent ↗

August 14, 2025

Via The Motley Fool

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

August 14, 2025

From MeiraGTx

Via GlobeNewswire

Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

May 14, 2025

Via Benzinga

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

May 13, 2025

Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell Therapy

From MeiraGTx

Via GlobeNewswire

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

May 13, 2025

From MeiraGTx

Via GlobeNewswire

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease

May 09, 2025

From MeiraGTx

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 13, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

March 13, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales ↗

March 13, 2025

Via Benzinga

G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday ↗

March 13, 2025

Via Benzinga

MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars ↗

March 13, 2025

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 13, 2025

Via Benzinga

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates

March 13, 2025

From MeiraGTx

Via GlobeNewswire

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process

March 13, 2025

From MeiraGTx

Via GlobeNewswire

MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy

February 21, 2025

From MeiraGTx

Via GlobeNewswire

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations

January 22, 2025

MeiraGTx has recently received Rare Pediatric Disease Designation (RPDD) for four inherited retinal diseases (IRDs) reflecting the transformative therapeutic potential of the Company’s proprietary...

From MeiraGTx

Via GlobeNewswire

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

December 09, 2024

From MeiraGTx

Via GlobeNewswire

MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates

November 13, 2024

From MeiraGTx

Via GlobeNewswire

Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good ↗

November 08, 2024

SoFi Technologies, Inc. is good, Jim Cramer said. It reported third-quarter adjusted sales of $689.445 million, according to Benzinga Pro.

Via Benzinga

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress

October 22, 2024

Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy Platforms

From MeiraGTx

Via GlobeNewswire

Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results ↗

October 15, 2024

Via Benzinga

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints ↗

October 15, 2024

MeiraGTx's clinical study of AAV-GAD for Parkinson's disease showed significant improvements in motor function and quality of life in high- and low-dose groups, with no serious adverse events....

Via Benzinga

Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views ↗

October 15, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.